New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

GNOMvsIBBETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of
BioTech & Genomics
-0.67%
VS
ETF 2
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
-1.08%

Global X Genomics & Biotechnology ETF - USD (GNOM) belongs to the BioTech & Genomics segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.44% for IBB. GNOM is up 0.74% year-to-date (YTD) with -$602K in YTD flows. IBB performs worse with 0.69% YTD performance, and -$200M in YTD flows. Run a side-by-side ETF comparison of GNOM and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs IBB performance and flow charts

Performance

0510%Mar 24Mar 31Apr 8Apr 15Apr 22

Cumulative Flows

0 M100 M200 M300 M400 MMar 24Mar 31Apr 8Apr 15Apr 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
IBB
+7.67%+5.04%
-7.03%-3.38%
+0.74%+0.69%
+41.51%+37.00%
-6.56%+28.67%
-50.60%+8.66%
Flows
GNOM
IBB
-$829K+$241M
+$1M-$196M
-$602K-$200M
-$14M+$775M
-$120M-$1.51B
+$1M-$1.91B
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
IBB
+28.47%+22.36%
+27.16%+21.19%
+28.79%+19.80%
+33.22%+22.08%
Max drawdown
GNOM
IBB
-16.08%-9.27%
-18.16%-9.61%
-46.50%-24.82%
-72.17%-39.75%
Max drawdown duration
GNOM
IBB
88d87d
92d92d
1075d377d
1758d1611d
Trading data

Create an account to view trading data

Join for free
GNOM
IBB
Last sale
4/27/2026 at 1:30 PM
$45.43
$169.02
Previous close
04/24/2026
$45.97
$169.78
Consolidated volume
04/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
GNOM
IBB
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
GNOM
IBB
Last price
$45.43
$169.02
1D performance
-1.17%
-0.45%
AuM$51.60 M$8.19 B
E/R0.5%0.44%
Characteristics
GNOM
IBB
Management strategyPassivePassive
ProviderGlobal XiShares
BenchmarkSolactive Genomics IndexICE Biotechnology Index
N° of holdings45179
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019February 5, 2001
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
87.57%
Other
12.43%
IBB
USA
95.97%
Other
4.03%

Sectors

GNOM
Health Care
88.49%
Other
11.51%
IBB
Health Care
85.68%
Other
14.32%
Advertisement

Diversification

GNOM

Total weight of top 15 holdings out of 15

66.21%
IBB

Total weight of top 15 holdings out of 15

55.88%

Top 15 holdings

Data as of March 31, 2026
GNOM
MODERNA INC
8.48%
ARROWHEAD PHARMACEUTICALS INC
6.21%
US74006W2070
6.13%
ILLUMINA
5.52%
GUARDANT HEALTH INC
5.18%
VERTEX PHARMACEUTICALS
4.61%
BIOMARIN PHARMACEUTICAL
4.59%
NATERA
4.21%
BIO-TECHNE CORP
3.64%
BIONTECH SE ADR
3.58%
CRISPR THERAPEUTICS
3.08%
BRISTOL-MYERS SQUIBB
3.05%
ALNYLAM PHARMACEUTICALS
2.85%
TWIST BIOSCIENCE CORP
2.54%
ASTRAZENECA
2.53%
IBB
GILEAD SCIENCES
7.75%
AMGEN-T
7.51%
VERTEX PHARMACEUTICALS
7.44%
REGENERON PHARMACEUTICALS
7.21%
ALNYLAM PHARMACEUTICALS
3.99%
INSMED
3.20%
US04016X1019
3.07%
BIOGEN INC
2.46%
NATERA
2.41%
UTD THERAPEUT
2.30%
US07725L1026
1.93%
INCYTE
1.70%
MODERNA INC
1.68%
ILLUMINA
1.68%
REVOLUTION MEDICINES INC
1.54%
Frequently asked questions about GNOM and IBB

How have the GNOM and IBB ETFs performed in 2026?

As of April 24, 2026, GNOM is up 0.74% year-to-date (YTD), while IBB has returned 0.69%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or IBB?

Year-to-date, the GNOM ETF saw -$602K in flows, compared to -$200M for IBB.

Which ETF is more volatile: GNOM or IBB?

Over the past year, GNOM had a volatility of 27.16%, while IBB experienced 21.19%.

Which ETF is bigger: GNOM or IBB?

As of April 24, 2026, GNOM holds $51.60 M in assets under management (AUM), while IBB manages $8.19 B.

What sectors do the GNOM and IBB ETFs invest in?

GNOM leans toward sectors like Health Care. Meanwhile, IBB focuses on Health Care.

What are the top holdings of the GNOM ETF and IBB ETF?

GNOM top holdings include MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. IBB holds in its top three: GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS.

Which ETF is more diversified: GNOM or IBB?

GNOM holds 47 securities with 66.21% of its assets in the top 15. IBB has 249 securities and a top 15 weight of 55.88%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder